-
Africa: NGOs and Drugmakers Slam Compromise Plan on Covid-19 Patents
allAfrica, 17 March 2022
The European Union, the U.S., India and South Africa have reached a provisional compromise on waiving Covid-19 vaccine intellectual property (IP) rights. Read more »
-
Africa: Top Economists and Oxfam Leader Demand Truly Just Covid IP Waiver
Common Dreams, 21 March 2022
"Like civil society groups around the world, we believe a bad deal is worse than no deal," they wrote to the South African president. Read more »
-
Africa: Media Reaction in Response to Reports of a Compromise On the Vaccines Trips Waiver
Oxfam, 16 March 2022
In response to reports of a potential compromise agreed by the EU, South Africa, India and the US for a waiver of intellectual property rules for COVID vaccines, Max Lawson, Head… Read more »
-
Africa: MSF Responds to Potential Compromise on the TRIPS Waiver
MSF, 17 March 2022
WTO members must demand that any formal TRIPS waiver agreement includes waiving IP on COVID-19 treatments and diagnostics, addresses intellectual property barriers beyond patents Read more »
-
South Africa: Why Not Supporting the Trips Covid-19 Waiver Contravenes International Human Rights
Daily Maverick, 1 December 2021
While more than 100 states support the proposal, powerful ones such as Canada, Germany, Japan, Norway, Switzerland and the UK, as well as the European Union, still do not, and may… Read more »
-
Africa: TRIPS Waiver - U.S. Support Is a Major Step but No Guarantee of Covid-19 Vaccine Equity
The Conversation Africa, 12 May 2021
In a momentous shift, the US recently agreed to support a waiver of the Trade Related Intellectual Property Rights (TRIPs) agreement at the World Trade Organisation (WTO). The… Read more »
-
Africa: What Does the 'TRIPS' Waiver Mean for Covid Vaccines?
The Conversation Africa, 7 May 2021
The US has announced its limited support for the "TRIPS waiver", a proposal to suspend intellectual property protections for products and technologies needed for the fight against… Read more »